环境与职业医学2025，Vol.42Issue(10)：1247-1251,5.DOI:10.11836/JEOM25046
基于敏捷治理视角的医药研发新业态职业健康管理策略探讨
Agile governance perspective on occupational health in evolving pharmaceutical research and development models
摘要
Abstract
The rapid development of the pharmaceutical research and development(R&D)has brought new challenges to occupational health management,including the high uncertainty in the R&D process,emerging hazards,and compliance complexities associated with novel business models.Traditional management approaches exhibit limitations in effectively addressing the oc-cupational health risks associated with these challenges.Based on the perspective of agile gover-nance,this paper proposed an optimized pathway characterized by dynamic response,adaptive flexibility,and multi-stakeholder collaboration.It further offered countermeasures and recom-mendations from three aspects:concept renewal,mechanism innovation,and tool empower-ment,aiming to provide reference for the effective management and control of occupational health risks in the innovation and development of the pharmaceutical R&D industry.关键词
医药/研发/新业态/职业健康管理/敏捷治理Key words
pharmaceutical/research and development/new business model/occupational health management/agile governance分类
预防医学引用本文复制引用
张霞,唐颖,于曼,陈健,朱素蓉..基于敏捷治理视角的医药研发新业态职业健康管理策略探讨[J].环境与职业医学,2025,42(10):1247-1251,5.基金项目
上海市卫生健康委员会标准预研制项目(2022WB12,2023WB18) （2022WB12,2023WB18）
